InvestorsHub Logo
Followers 140
Posts 11663
Boards Moderated 0
Alias Born 03/15/2011

Re: None

Monday, 06/03/2013 9:13:23 AM

Monday, June 03, 2013 9:13:23 AM

Post# of 346222
Cramer on CNBC about Merck, BMS, etc

He says BMS is becoming a Biotech.
Long since we heard from Merck he says with something of value (Skin Cancer).

Making the immune system suppress cancers is the future. They used the word "attack".

Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News